Natural product-inspired fragment-based drug discovery: Development of M. tuberculosis CYP121 inhibitors

被引:0
|
作者
Kavanagh, Madeline [1 ]
Gray, Janine [1 ]
Coyne, Anthony [1 ]
Davis, Holly [1 ]
McLean, Kirsty [2 ]
Munro, Andrew [2 ]
Abell, Christopher [1 ]
机构
[1] Univ Cambridge, Dept Chem, Cambridge, England
[2] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
818
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Identifying small molecule inhibitors of Fascin 1 using fragment-based drug discovery
    Croft, Daniel
    Francis, Stuart
    Bower, Justin
    Gohlke, Andrea
    Goodwin, Gillian
    Gray, Christopher
    Konczal, Jennifer
    Macconnachie, Sophie
    McConnell, Patricia
    McDonald, Laura
    McKinnon, Heather
    Mezna, Mokdad
    Parry, Charles
    Paul, Nikki
    Pugliese, Angelo
    Schuettelkopf, Alexander
    Machesky, Laura
    Drysdale, Martin
    CANCER RESEARCH, 2017, 77
  • [42] When fragments link: a bibliometric perspective on the development of fragment-based drug discovery
    Romasanta, Angelo K. S.
    van der Sijde, Peter
    Hellsten, Iina
    Hubbard, Roderick E.
    Keseru, Gyorgy M.
    van Muijlwijk-Koezen, Jacqueline
    de Esch, Iwan J. P.
    DRUG DISCOVERY TODAY, 2018, 23 (09) : 1596 - 1609
  • [43] Synthesis of natural product-inspired inhibitors of Mycobacterium tuberculosis mycothiol-associated enzymes:: The first inhibitors of GlcNAc-Ins deacetylase
    Metaferia, Belhu B.
    Fetterolf, Brandon J.
    Shazad-ul-Hussan, Syed
    Moravec, Matthew
    Smith, Jeremy A.
    Ray, Satyajit
    Gutierrez-Lugo, Maria-Teresa
    Bewley, Carole A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (25) : 6326 - 6336
  • [44] Screening and Identification of Lassa Virus Entry Inhibitors from a Fragment-Based Drug Discovery Library
    Hou, Yuxia
    Liu, Yang
    Jia, Xiaoying
    Zhou, Minmin
    Mao, Wenting
    Dong, Siqi
    Zhang, Yueli
    Xiao, Gengfu
    Wang, Wei
    VIRUSES-BASEL, 2022, 14 (12):
  • [45] Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
    Narayanan, Dilip
    Tran, Kim T.
    Pallesen, Jakob S.
    Solbak, Sara M. O.
    Qin, Yuting
    Mukminova, Elina
    Luchini, Martina
    Vasilyeva, Kristina O.
    Chichon, Dorleta Gonzalez
    Goutsiou, Georgia
    Poulsen, Cecilie
    Haapanen, Nanna
    Popowicz, Grzegorz M.
    Sattler, Michael
    Olagnier, David
    Gajhede, Michael
    Bach, Anders
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (21) : 14481 - 14526
  • [46] Fragment-based drug discovery to identify small molecule allosteric inhibitors of SHP2
    Day, Philip J.
    Berdini, Valerio
    Castro, Juan
    Chessari, Gianni
    Davies, Thomas G.
    Day, James E.
    Fukaya, Satoshi
    Hamlett, Chris
    Hearn, Keisha
    Hiscock, Steve
    Holvey, Rhian
    Ito, Satoru
    Kodama, Yasuo
    Matsuo, Kenichi
    Nakatsuru, Yoko
    Palmer, Nick
    Price, Amanda
    Shimamura, Tadashi
    St Denis, Jeffrey D.
    Wallis, Nicola G.
    Williams, Glyn
    Johnson, Christopher N.
    CANCER RESEARCH, 2020, 80 (16)
  • [47] A fragment-based drug discovery strategy applied to the identification of NDM-1 β-lactamase inhibitors
    Caburet, Jeremy
    Boucherle, Benjamin
    Bourdillon, Sofiane
    Simoncelli, Giorgia
    Verdirosa, Federica
    Docquier, Jean-Denis
    Moreau, Yohann
    Krimm, Isabelle
    Crouzy, Serge
    Peuchmaur, Marine
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 240
  • [48] Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria
    Moreau, Robert J.
    Skepper, Colin K.
    Appleton, Brent A.
    Blechschmidt, Anke
    Balibar, Carl J.
    Benton, Bret M.
    Drumm, Joseph E., III
    Feng, Brian Y.
    Geng, Mei
    Li, Cindy
    Lindvall, Mika K.
    Lingel, Andreas
    Lu, Yipin
    Mamo, Mulugeta
    Mergo, Wosenu
    Polyakov, Valery
    Smith, Thomas M.
    Takeoka, Kenneth
    Uehara, Kyoko
    Wang, Lisha
    Wei, Jun-Rong
    Weiss, Andrew H.
    Xie, Lili
    Xu, Wenjian
    Zhang, Qiong
    de Vicente, Javier
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (08) : 3309 - 3324
  • [49] Structure-based drug design of novel M. tuberculosis InhA inhibitors based on fragment molecular orbital calculations
    Phusi, Naruedon
    Hashimoto, Yuta
    Otsubo, Naoki
    Imai, Kyohei
    Thongdee, Paptawan
    Sukchit, Darunee
    Kamsri, Pharit
    Punkvang, Auradee
    Suttisintong, Khomson
    Pungpo, Pornpan
    Kurita, Noriyuki
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 152
  • [50] Discovery of the first Mycobacterium tuberculosis MabA (FabG1) inhibitors through a fragment-based screening
    Faion, Leo
    Djaout, Kamel
    Frita, Rosangela
    Pintiala, Catalin
    Cantrelle, Francois-Xavier
    Moune, Martin
    Vandeputte, Alexandre
    Bourbiaux, Kevin
    Piveteau, Catherine
    Herledan, Adrien
    Biela, Alexandre
    Leroux, Florence
    Kremer, Laurent
    Blaise, Mickael
    Tanina, Abdalkarim
    Wintjens, Rene
    Hanoulle, Xavier
    Deprez, Benoit
    Willand, Nicolas
    Baulard, Alain R.
    Flipo, Marion
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 200